Wound Care and Pressure Injury Through the Continuum of Care
Our primary objective is to understand the impact of our quality improvement objectives on pressure injury and wound care outcomes. We will follow patients admitted to our facility who receive the standard of care for a up to a year. Patients to be followed will fall into one of four groups: acute wounds, chronic wounds, pressure injuries present at time of admission and at risk for pressure injuries.
NCT04649853 — Wound
Status: Enrolling by invitation
http://inclinicaltrials.com/wound/NCT04649853/
Lower Extremity Venous and Diabetic Ulcer Negative Pressure Wound Therapy Trial.
The purpose of this study is to evaluate a novel negative pressure wound therapy (NPWT) device called the SNaP device compared to a traditional NPWT device for the treatment of lower extremity diabetic and venous ulcer wounds.
NCT00951080 — Wounds
Status: Completed
http://inclinicaltrials.com/wounds/NCT00951080/
The Mobile Applications (APP) for Patient Education Has Promoted the Knowledge, Skills on the Wound Care and Reduced the Anxiety of Wound Care
The purposes of this study were to understand the effects of mhealth App on wound care knowledge, wound care skills, and anxiety related to dressing change when compared to traditional health education before patients discharged from hospital.
NCT03683303 — Wound
Status: Completed
http://inclinicaltrials.com/wound/NCT03683303/
Phase 2-3 Observational Wound Care Study Comparing Application of Platelet Rich Plasma With Standard of Care Wound Closure in Vascular Patients Requiring a Groin Incision.
The use of platelet rich plasma will decrease wound infection postop.
NCT00517452 — Atherosclerosis
Status: Completed
http://inclinicaltrials.com/atherosclerosis/NCT00517452/
Comparing Ice Therapy and Warm Baths for Hemorrhoidectomy Wound Care
This study aims to compare the effectiveness of cryotherapy and warm water sitz bath in post-hemorrhoidectomy wound care. It is a prospective, randomized controlled trial that will assess the impact of these two methods on postoperative pain, analgesic use, wound separation, and swelling.
NCT06460402 — Post Operative Pain
Status: Enrolling by invitation
http://inclinicaltrials.com/post-operative-pain/NCT06460402/
A Two-Part, Randomized Study of Dermacyte® Amniotic Wound Care Matrix for the Treatment of Diabetic Foot Ulcers (DFU)
This is a multi-center, prospective, two-part, controlled study to determine the percentage of participants with complete ulcer closure of a target DFU at Week 12 following treatment with Dermacyte Matrix or SOC.
NCT06444906 — Diabetic Foot Ulcer
Status: Not yet recruiting
http://inclinicaltrials.com/diabetic-foot-ulcer/NCT06444906/
Evaluation of Adhesion Properties in Wound Care Devices
Molnlycke manufactures and markets self-adhesive wound care devices intended to protect various types of wounds during treatment. This study aims to measure and evaluate the adhesion properties of self-adhesive wound care devices. To measure the adhesion properties test strips will be applied to the participant's skin for a predetermined time and will be removed while measuring the adhesion properties afterwards. This method has been chosen since there is no in vitro method available that can simulate adhesion to human skin
NCT06392165 — Adhesion Properties of Wound Care Devices
Status: Not yet recruiting
http://inclinicaltrials.com/adhesion-properties-of-wound-care-devices/NCT06392165/
An Observational Clinical Registry to Collect Safety and Efficacy Data on Wound Care in Medical Centers
Collect data on various wound treatments and their related wound healing process, in real life settings. Analyze the safety and efficacy of wound treatments, including: advanced biological/synthetic grafts and standard of wound care treatments.
NCT06328010 — Burns
Status: Enrolling by invitation
http://inclinicaltrials.com/burns/NCT06328010/
Assessment of Wound Healing, Cooling Efficacy and Local Tolerability of a Wound Care Hydrogel With Intraindividual Comparison Using an Abrasive Wound Model in a Single-center, Randomized, Investigatorblind Clinical Investigation.
Test the wound healing properties of the product as well as the cooling effect and tolerability of a wound care gel.
NCT06309446 — Wound
Status: Completed
http://inclinicaltrials.com/wound/NCT06309446/
Post-market Clinical Follow-up Study for a CE Marked Wound Care Product (FibDex®) to Compare the Clinical Performance and Safety in it's Established Intended Use of Split Thickness Skin Graft Donor Site Wounds
FibDex® 2-2022 is a sponsored, post-marketing clinical follow-up (PMCF) study to monitor the clinical performance and safety of the CE marked product nanofibrillar cellulose (NFC) wound dressing, FibDex®, when used according to its intended use for patients or individuals with split thickness skin graft (STSG) donor site wounds and to compare clinical performance and safety of FibDex® to current clinical practice.
NCT05666999 — Skin Transplantation
Status: Not yet recruiting
http://inclinicaltrials.com/skin-transplantation/NCT05666999/